Mangalam Drugs & Organics Ltd has disclosed ongoing loan defaults totaling Rs 15.57 crore across Bank of Maharashtra and Bank of Baroda. The company has been in breach of its credit obligations since October 2025, signaling persistent liquidity constraints. Investors should monitor management's repayment timeline and potential implications for credit health.
Mangalam Drugs & Organics Reports Loan Defaults
Total overdue amount: Rs 15.57 crore.
Duration: Defaults active since October 2025.
Reader Takeaway: Persistent liquidity strain evidenced by year-long debt defaults; management aims to repay, but no timeline provided.
What just happened
Mangalam Drugs & Organics Ltd has issued a mandatory disclosure under SEBI regulations confirming continued defaults on its cash credit facilities. As of October 15, 2026, the company holds Rs 9.51 crore in overdue payments with Bank of Maharashtra and Rs 6.06 crore with Bank of Baroda. These obligations have remained unpaid for approximately 12 months, with default dates originating in October 2025.
Why this matters
For equity investors, this filing underscores a prolonged liquidity crisis. The company's inability to clear these dues over a full calendar year highlights severe working capital pressure. While the disclosure is a routine compliance requirement, the ongoing nature of the default raises concerns regarding the company’s near-term debt servicing capacity and operational stability.
What changes now
Management, headed by Managing Director Govardhan M. Dhoot, has stated they are actively arranging funds to settle these liabilities. However, the lack of a concrete repayment schedule maintains uncertainty for shareholders. Investors should look for updates regarding debt restructuring or any formal repayment agreements reached with the lenders.
Risks to watch
Key risks include potential adverse actions by lenders, possible downgrades in credit ratings, and further strain on cash flow. The persistence of these defaults suggests that the company’s internal accruals may be insufficient to cover debt obligations under current conditions.
What to track next
Watch for subsequent BSE filings regarding any reduction in the overdue amount or formal letters of settlement from the banking institutions involved.